A
Avagar Nexus
Platinum
- Joined
- Apr 19, 2025
- Posts
- 1,234
- Reputation
- 599
So with all this data, why do u see a considerable amount of people complaining bout sides. I mean yeah sure, u could say that it seems so because the ones who do fine don’t complain, but still. From the day it would seem it’s very safe?!
Topical finasteride 2.275 mg/mL vs oral finasteride 1 mg vs placebo
24-week randomized trial:
Sexual-function questionnaire: no significant difference between topical finasteride and placebo at 12 or 24 weeks.
Systemic exposure:
Sources: Piraccini et al., JEADV 2022; Propecia prescribing information; Overstreet et al., Journal of Urology 1999.
Topical finasteride 2.275 mg/mL vs oral finasteride 1 mg vs placebo
24-week randomized trial:
| Outcome | Topical fin | Placebo | Oral fin |
|---|---|---|---|
| Treatment-related sexual AEs | 2.8% | 3.3% | 4.8% |
| No reported treatment-related sexual AE | 97.2% | 96.7% | 95.2% |
| Reduced/lost libido | 0.6% | 2.8% | 4.8% |
| Discontinued due to sexual AE | 0% | 1.1% | 2.4% |
Systemic exposure:
- Maximum plasma finasteride: >100× lower with topical than oral
- Serum DHT reduction: ~34.5% topical vs ~55.6% oral
- Decreased libido: 1.8% fin vs 1.3% placebo
- ED: 1.3% vs 0.7%
- Ejaculation disorder: 1.2% vs 0.7%
- Decreased ejaculate volume: 0.8% vs 0.4%
- Any reported sexual AE: 3.8% vs 2.1%
- No reported sexual AE: 96.2% vs 97.9%
- No significant effect on sperm concentration
- No significant effect on total sperm count
- No significant effect on motility
- No significant effect on morphology
- Median ejaculate-volume change: −0.3 mL finasteride vs −0.2 mL placebo, not significantly different
- Penis size
- Penile sensation
- Exact erection fullness
- Fynzur-specific sperm quality/fertility over the long term
Sources: Piraccini et al., JEADV 2022; Propecia prescribing information; Overstreet et al., Journal of Urology 1999.